Terms: = Pancreatic cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2
8 results:
1. The origin of exosomal miR-1246 in human cancer cells.
Xu YF; Hannafon BN; Khatri U; Gin A; Ding WQ
RNA Biol; 2019 Jun; 16(6):770-784. PubMed ID: 30806147
[TBL] [Abstract] [Full Text] [Related]
2. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
You L; Wang H; Yang G; Zhao F; Zhang J; Liu Z; Zhang T; Liang Z; Liu C; Zhao Y
Mol Oncol; 2018 Dec; 12(12):2147-2164. PubMed ID: 30341811
[TBL] [Abstract] [Full Text] [Related]
3. Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells.
Butkytė S; Čiupas L; Jakubauskienė E; Vilys L; Mocevicius P; Kanopka A; Vilkaitis G
Clin Epigenetics; 2016; 8():33. PubMed ID: 27019673
[TBL] [Abstract] [Full Text] [Related]
4. DICER, drosha and DNA damage response RNAs are necessary for the secondary recruitment of DNA damage response factors.
Francia S; Cabrini M; Matti V; Oldani A; d'Adda di Fagagna F
J Cell Sci; 2016 Apr; 129(7):1468-76. PubMed ID: 26906421
[TBL] [Abstract] [Full Text] [Related]
5. TRAIL mediated signaling in pancreatic cancer.
Nogueira DR; Yaylim I; Aamir Q; Kahraman OT; Fayyaz S; Kamran-ul-Hassan Naqvi S; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(15):5977-82. PubMed ID: 25124560
[TBL] [Abstract] [Full Text] [Related]
6. Menin is required for optimal processing of the microRNA let-7a.
Gurung B; Muhammad AB; Hua X
J Biol Chem; 2014 Apr; 289(14):9902-8. PubMed ID: 24563463
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract] [Full Text] [Related]
8. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
Nudelman A; Rephaeli A
J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204
[TBL] [Abstract] [Full Text] [Related]
